)
DRI Healthcare Trust (DHT-UN) investor relations material
DRI Healthcare Trust Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved record financial performance in 2025, with total income of $198.6 million and total cash receipts of $196.4 million, surpassing deployment and royalty income targets, and completing internalization of management to enhance governance and cost efficiency, expected to generate $200 million in synergies over 10 years.
Deployed and committed over $200 million in 2025, including $87 million deployed and $115 million in contingent commitments, meeting five-year deployment targets and supporting double-digit CAGR in royalty income.
Returned over $36 million to unitholders via unit repurchases and increased dividends, while reducing preferred share obligations and enhancing capital flexibility.
Executed a new corporate structure, optimized cost structure, and implemented a proprietary risk assessment framework, driving margin expansion and operational efficiency.
Positioned for continued growth with a robust pipeline exceeding $3 billion in potential opportunities, leveraging AI integration and a strengthened team.
Financial highlights
Total income for 2025 reached $198.6 million, up 6% year-over-year; total cash receipts were $196.4 million, up 3%; Adjusted EBITDA for 2025 was $165.0 million, up 5%, with a margin of 84% (normalized to 88% excluding non-recurring costs); Q4 2025 Adjusted EBITDA was $46.2 million with a 91% margin.
Adjusted cash earnings per unit for 2025 were $2.26; declared cash distributions per unit were $0.40; quarterly distribution increased to $0.11 per unit for Q1 2026.
Repurchased and canceled 1.4 million units in 2025 for $14.2 million, reducing unit count by nearly 3%.
Paid total cash distributions of $22.2 million in 2025.
Comprehensive loss for the year was $51.1 million, impacted by $23.4 million in impairments on Vonjo II and Omidria royalty assets.
Outlook and guidance
2026 Adjusted EBITDA guidance set at $157–$162 million, based on a normalized 2025 baseline excluding $15.7 million in non-recurring royalty recoveries.
Multi-year capital deployment target of $800–$1,000 million for 2026–2030, fully funded by existing capital and cash flows.
Targeting a low teens CAGR in Adjusted EBITDA through 2030, with sequential acceleration and no need for additional equity.
Royalty income CAGR tracking at 12% from a 2022 base, above prior high single-digit guidance.
Increased quarterly distribution to $0.11 per unit for Q1 2026.
Next DRI Healthcare Trust earnings date
Next DRI Healthcare Trust earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)